Determination of the CD148-Interacting Region in Thrombospondin-1

Keiko Takahashi1, Katherine Sumarriva1, Rachel Kim1

  • 1Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.

Plos One
|May 6, 2016
PubMed

Insights

Thrombospondin-1's (TSP1) first type 1 repeat specifically binds CD148, inhibiting cell proliferation and angiogenesis by reducing growth factor signaling. This interaction is crucial for CD148's anti-proliferative and anti-angiogenic functions.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • CD148 is a transmembrane protein tyrosine phosphatase that suppresses cell proliferation.
  • Thrombospondin-1 (TSP1) is a ligand for CD148, with complex signaling effects.
  • Identifying the specific TSP1 region interacting with CD148 is key to understanding its function.

Purpose of the Study:

  • To identify the CD148-interacting region within TSP1.
  • To investigate the functional consequences of this interaction on cell signaling and proliferation.
  • To determine the role of this interaction in endothelial cell proliferation and angiogenesis.

Main Methods:

  • Biochemical assays to map TSP1 fragments binding to CD148.
  • Cell proliferation assays using engineered cell lines (A431D/CD148wt, CD148-deficient, catalytically inactive CD148).
  • Western blotting to assess phosphorylation of downstream targets (EGFR, ERK1/2).
  • In vitro endothelial cell proliferation and in vivo angiogenesis assays.

Main Results:

  • The first type 1 repeat of TSP1 was identified as the CD148-binding region.
  • Trimeric TSP1 fragments containing the first type 1 repeat inhibited proliferation in CD148-expressing cells.
  • This TSP1 fragment enhanced CD148 activity, reduced phospho-tyrosine levels of EGFR and ERK1/2, and inhibited endothelial cell proliferation and angiogenesis.
  • These effects were dependent on CD148 expression and catalytic activity.

Conclusions:

  • The first type 1 repeat of TSP1 is a specific functional ligand for CD148.
  • This interaction mediates CD148's ability to reduce growth factor signaling, inhibit cell proliferation, and suppress angiogenesis.
  • Targeting the TSP1-CD148 interaction could offer therapeutic strategies for conditions involving excessive cell growth or angiogenesis.